Literature DB >> 15559051

Pathology of mesothelioma.

Joseph M Corson1.   

Abstract

In this article, progress in distinguishing mesothelioma from mesothelial hyperplasia and fibrosing pleuritis was discussed. Advances in the immunohistochemical characterization of mesothelioma, in the recognition of entities that mimic mesothelioma, and in their distinction from mesothelioma were reviewed. Cytogenetic and molecular genetic contributions to the diagnosis of pleural synovial sarcoma were briefly summarized. The diagnosis of epithelial type mesothelioma can be established in most cases. Several mesotheliomas, however, especially rare subtypes, and sarcomatoid, desmoplastic, and poorly differentiated mesotheliomas continue to present diagnostic challenges.

Entities:  

Mesh:

Year:  2004        PMID: 15559051     DOI: 10.1016/j.thorsurg.2004.06.007

Source DB:  PubMed          Journal:  Thorac Surg Clin            Impact factor:   1.750


  4 in total

1.  Identification of MCAM/CD146 as the target antigen of a human monoclonal antibody that recognizes both epithelioid and sarcomatoid types of mesothelioma.

Authors:  Scott Bidlingmaier; Jiang He; Yong Wang; Feng An; Jinjin Feng; Dario Barbone; Dongwei Gao; Ben Franc; V Courtney Broaddus; Bin Liu
Journal:  Cancer Res       Date:  2009-02-03       Impact factor: 12.701

Review 2.  Mesothelioma.

Authors:  Nagarjun Rao; Shuanzeng Wei
Journal:  Cytojournal       Date:  2022-02-28       Impact factor: 2.345

Review 3.  Malignant mesothelioma as a difficult interdisciplinary problem.

Authors:  Wojciech Rokicki; Marek Rokicki; Jacek Wojtacha; Mateusz K Rydel
Journal:  Kardiochir Torakochirurgia Pol       Date:  2017-12-20

Review 4.  Introduction to the second edition of 'Diagnostic Cytopathology of Serous Fluids' as CytoJournal Monograph (CMAS) in Open Access.

Authors:  Vinod B Shidham; Lester J Layfield
Journal:  Cytojournal       Date:  2021-12-06       Impact factor: 2.091

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.